CSTL

Castle Biosciences Inc.

Price

$32.32

return (12m)

62.41%

p/e

-46.28

p/bv

1.91

DIVIDEND YIELD

0.00%

CSTL price

Castle Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment CSTL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

33.17%

3 months

57.35%

1 year

62.41%

2 years

15.59%

5 years

-51.19%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals CSTL

Valuation

P/E

-46.28

Sector -4.38

Industry -4.38

P/BV

1.91

Sector 2.02

Industry 2.02

P/Revenue (PSR)

2.51

Sector -4.40

Industry -4.40

EV/EBITDA

248.46

Sector -263.09

Industry -263.09

EV/EBIT

-425.70

Sector -702.90

Industry -702.90

P/EBITDA

-277.22

Sector -4.39

Industry -4.39

P/EBIT

-47.70

Sector -4.73

Industry -4.73

P/Total Assets

1.60

Sector 1.49

Industry 1.49

P/Net Current Assets

3.59

Sector -11.70

Industry -11.70

P/Working Capital

3.16

Sector -3.19

Industry -3.19

EPS

-0.65

Sector -2.14

Industry -2.14

BVPS

15.67

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

77.26%

Sector 36.74%

Industry 36.74%

EBITDA Margin

2.48%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-1.45%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-8.99%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-5.43%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.18

Sector 0.03

Industry 0.03

Profitability

ROE

-4.13%

Sector -65.14%

Industry -65.14%

ROA

-3.46%

Sector -65.53%

Industry -65.53%

ROIC

-4.56%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.04

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-101.03

Sector -6.07

Industry -6.07

Net Debt / EBIT

173.10

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.55

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.02

Sector -0.05

Industry -0.05

Equity/Assets

0.84

Sector 0.41

Industry 0.41

Liabilities/Assets

0.16

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

30.58%

Sector -

Industry -

5Y Earnings CAGR

-9.11%

Sector -

Industry -

Fundamentals CSTL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
CSTL Castle Biosciences Inc.	$32.32	57.20%	0.00%	-46.28	1.91	-4.13%	-5.43%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

CSTL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Castle Biosciences

Castle Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

19 years

Founded: 2007

2019

Time since IPO - 7 years

201

Employees

Castle Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $898.20 million, with shareholders equity totaling $470.03 million.

The company employs approximately 201 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Castle Biosciences Inc. reported $357.28 million in revenue, generating net income of $-19.41 million.

Key financial metrics include a P/E ratio of -46.28, a price-to-book (P/B) ratio of 1.91, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker CSTL.

Market cap

$898.20 million

Net worth

$470.03 million

$470,030,000.00

Assets

$561.18 million

$561,180,000.00

Total Shares Outstanding

30.00 million

30,000,000

Average Daily Trading Volume

$399.62 Thousand

$399,619.50

Sector

Health Care

Industry

Biotechnology

CSTL

CSTL revenue and profits

Financial Results CSTL

DRAG THE FRAME TO SEE MORE DATA

CSTL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Castle Biosciences (CSTL) today?

A cotação de Castle Biosciences (CSTL) hoje está em US$ 32.32, com uma variação de 62.41% em relação ao último ano. A cotação de Castle Biosciences (CSTL) iniciou o ano negociando na casa dos US$ 38.90 e hoje está em US$ 32.32. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Castle Biosciences (CSTL) e dados de ações do Ibovespa e mercados internacionais.

Quando Castle Biosciences (CSTL) paga dividendos?

Castle Biosciences (CSTL) não distribuiu dividendos no último ano.

Is Castle Biosciences (CSTL) a good investment?

Atualmente, Castle Biosciences (CSTL) está cotada a US$ 32.32, com um P/L de -46.28, representando um desvio de -1,437% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 62.41 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 62.41%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Castle Biosciences (CSTL) stock?

Investir em ações de Castle Biosciences (CSTL) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Castle Biosciences (CSTL) yield today?

A rentabilidade de Castle Biosciences (CSTL) foi de 33.17% no último mês, 62.41% no último ano e -51.19% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Castle Biosciences (CSTL) hoje, o investimento total seria de US$ 3,232.00, com base na cotação atual de US$ 32.32.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5,249.09
Em 5 anos: US$ 1,577.54
Em 10 anos: US$ 3,232.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

CSTL

Castle Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment CSTL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING CSTL WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Castle Biosciences

Castle Biosciences Inc.

United States

19 years

2019

201

PROFIT X PRICE CSTL

Financial Results CSTL

CSTL cash flow

Asset, Revenue and Profit Growth - CSTL

CSTL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions